Health In Tech Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Health In Tech stock has a target of 2.50, which predicts an increase of 119.30% from the current stock price of 1.14.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.50	$2.50	$2.50	$2.50
Change	+119.30%	+119.30%	+119.30%	+119.30%

* Price targets were last updated on Jun 26, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Health In Tech is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Allen Klee Maxim Group	Maxim Group	Strong Buy Initiates $2.5	Strong Buy	Initiates	$2.5	+119.30%	Jun 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

33.14M

from 19.49M

70.02%

from 19.49M

Revenue Next Year

47.75M

from 33.14M

44.08%

from 33.14M

EPS This Year

0.04

from 0.01

304.00%

from 0.01

EPS Next Year

0.09

from 0.04

112.50%

from 0.04

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	5.77M	19.15M	19.49M	33.14M	47.75M	75.78M
Revenue Growth	-	231.93%	1.77%	70.02%	44.08%	58.71%
EPS	0.00	0.05	0.01	0.04	0.09	0.28
EPS Growth	-	2,788.89%	-79.10%	304.00%	112.50%	229.41%
Forward PE	-	-	-	28.22	13.28	4.03
No. Analysts	-	-	-	3	3	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	35.7M	56.3M
Avg	33.1M	47.7M
Low	31.0M	40.1M

Revenue Growth

Revenue Growth	2025	2026
High	83.2%	69.9%
Avg	70.0%	44.1%
Low	58.9%	21.1%

EPS Forecast

EPS	2025	2026
High	0.07	0.18
Avg	0.04	0.09
Low	0.01	-

EPS Growth

EPS Growth	2025	2026
High	635.0%	341.8%
Avg	304.0%	112.5%
Low	-2.0%	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.